Shares of Corbus Pharmaceuticals Holdings Inc. CRBP,
jumped 10.88% to $ 3.42 Wednesday, in what proved to be a fully mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA,
increasing 0.20% to 31,437.80 and the NASDAQ Composite Index COMP,
falling 0.25% to 13,972.53. This was the third consecutive day of earnings for the stock. Corbus Pharmaceuticals Holdings Inc. closed $ 6.37 below its 52-week high ($ 9.78), which the company reached on August 31.
The stock outpaced some of its competitors on Wednesday, like Fate Therapeutics Inc. FATE,
fell 1.91% to $ 103.31, Vanda Pharmaceuticals Inc. VNDA,
fell 0.58% to $ 15.41, and Viking Therapeutics Inc. VKTX,
fell 2.09% to $ 8.89. Turnover (66.0 million) exceeded its average 50-day volume of 12.8 million.
Editor’s note: this story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.